Form 4 for VKTX Viking Therapeutics, Inc.
Accepted 2024-10-25 00:00:00 ET · period of report 2024-10-25 · accession 0000950170-24-117513 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-10-25 | 2024-10-25 | VKTX | SINGLETON J MATTHEW | Dir | S - Sale+OE | $79.50 | -16.0K | 9,500 | -63% | -$1.27M |
| DT | 2024-10-25 | 2024-10-25 | VKTX | SINGLETON J MATTHEW | Dir | M - OptEx | $4.48 | +16.0K | 25.5K | +168% | +$71.7K |
| DT | 2024-10-25 | 2024-10-25 | VKTX | SINGLETON J MATTHEW | Dir | M - OptEx | $0.00 | -16.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.00001 per share | 2024-10-25 | S | D | 16,000 | $79.50 | 9,500 | D | — | — | |
| 2 | Common | Common Stock, par value $0.00001 per share | 2024-10-25 | M | A | 16,000 | $4.48 | 25,500 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-10-25 | M | D | 16,000 | $0.00 | 0 | D | $4.48 · 2019-01-02 to 2028-01-02 | 16,000 Common Stock |